Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do you know who owns the shares now? I think I remember you mentioning someone who might be the new owner of them. You should find various ways to try and get ahold of them just to see what their plans are. If it’s someone that doesn’t really care about it then you could offer them, let’s say, $200k for the 35 million shares that he/she owns. Would be kind of a fun side gig if the company doesn’t have any liabilities.
I can totally understand why you wouldn’t want to do it though. Maybe the new owner of the shares could show interest in selling somehow.
Do you know what the current OS is here? Is it still around 38 million?
Nice bid/ask spread for MYRX. .0465 x .048
You must own quite a few shares by now! ENZN should have its 10-K released any day now. Last year it was released on Wednesday February 19, 2020
I’m hoping there will be some clues in it.
I’m sorry to hear that. That must have been hard for her to go through.
I was actually getting ready to do some research to see how often the FDA approves fast tracked drugs early. I will let you know what I find.
That is beyond amazing man! I’m really happy for you. I knew you would eventually hit it big! I have a feeling you will do it again.
I’m still holding some TRAE here. You should consider creating a LLC and take this thing over. Do you know if TRAE has any NOL’s? If so, I wonder if you buy this on the cheap and utilize the NOL’s against your GME profits so that it would be tax free income?
Another day of someone trying to buy 100k blocks of shares. That will be hard to get as we thin out while moving higher
I agree. It’s crazy to think that ENZN could get around $200 million over the next 10 years from royalties and milestone payments if/when Vicineum is approved in August.
And that won’t even be their main source of income in the future. This is going to get exciting soon.
We should be getting earnings soon...
Priority review accepted by FDA for Vicineum!! Approval date decision is in August. $ENZN should see a nice move higher going into the summer
$MYRX’s cash/cash equivalents should be over $1.4 million now (cash + ENZN shares held) which is about equal to the current market cap of about $1.4 million at the current .04 price per share. This essentially means MYRX should be moving higher now as ENZN will continue to move higher with everything it has going for it right now
I’m ready for ENZN’s coming phenomenal year to take place. It will cause MYRX to trade north of $1 IMO
I’m loaded with shares of both. I now have the max shares of MYRX that people are allowed to buy.
I also think we will wake up to huge news regarding a merger sometime this year at the latest. I’m sure Icahn will be reaching out to profitable private companies that would be a good fit for ENZN.
The current CEO retires at the end of this month. The CFO will take on the CEO responsibilities along with his current duties. ENZN won’t be adding any more executives to fill in the vacancy. There is only one reason I can think of for this. Its probably because executives from the private company utilizing ENZN’s NOL’s will fill in the vacancy IMO
ENZN has two really good things going for it. After a merger and Vicineum is approved, there is no way ENZN will be trading below $10 anymore.
I have a really good feeling (like 100% feeling) that Vicineum will get fast track approval. This alone would be a good sign for FDA approval IMO. I think ENZN will see multi year highs this week.
The Vicineum royalties alone are huge potential for ENZN. Not to mention ENZN’s purpose as a “public company acquisition vehicle” as mentioned on their website.
Way undervalued considering its huge potential
I’m still trying to figure out why MYRX bought ENZN shares as well. At some point MYRX should be rising along with ENZN as that stock continues higher or else the total value of ENZN shares that MYRX holds will be higher than MYRX’s market cap.
I think we will do good with MYRX just off ENZN alone. ENZN could easily be a $5 stock when they buy a profitable company to utilize the NOL’s Icahn own about half of that one so I imagine he will find a company fairly quick given his connections.
Also ENZN could get up to $20 million or so in worldwide royalties from Vicineum for 10 years once approved.
That is a lot of money for a stock with a market cap of only $52 million right now since they already have $48 million in cash with no debt.
This should help put MYRX in the spotlight
$ENZN should have a really good week this week. We find out on Tuesday if Vicineum gets fast track approval and when the FDA decision will be. ENZN will get $3.5 million in Milestone payments for each country it’s approved in along with an estimated $20 million in worldwide royalties from Vicineum.
This will be huge!
Are you sure that’s all it will take to bring it to “pink current”? Where did you find this at?
Thanks. Do you mainly Nasdaq and NYSE stocks? Or can you buy OTCQX that are fully reporting like ENZN?
It’s crazy that MYRX market cap is only just over $1 million when other shell stocks with no NOL’s like AWGI have a $16 million market cap. AWGI doesn’t have assets while MYRX has $147 million NOL’s, cash, and over 660,000 shares of ENZN.
MYRX deserves to be much higher
$MYRX - This is going to wake up soon IMO. Someone keeps bidding 100k+ blocks of shares. Once it’s filled or partially filled, another large block shows up at the bid. Smart way to quietly accumulate a large amount of shares instead of putting like a 1 million share bid that would cause attention.
$ENZN - awesome post! I’m getting very excited for Tuesday! Going to be a phenomenal week for Enzon
$MYRX - It’s a bummer you can’t but it with your broker. Lots of potential with that one to be used in a merger. Only $1 million market cap too. Similar stocks have $7-20 million + market caps.
MYRX .04 owns 1.4% of ENZN and has $147 million NOL’s. Not noticed yet. Only $1 million market cap. CEO is known for reverse mergers!
Icahn just bought a large stake in Bausch Health and sounds like they want to spin off the eye health division via a possible SPAC merger. Icahn owns half of $ENZN!
) PROCEED WITH PACE: The spin-off should be completed by year-end 2021.
In order to facilitate the spin-off of Bausch Global Eyecare as an investment grade Company, we recommend Bausch Health Companies retain a globally recognized investment banking firm to seek capital for an up to a 40% equity stake in BGE prior to its spin-off. To be clear, we are recommending raising capital by selling a stake in the eyecare subsidiary, BGE, at fair value, and we specifically recommend against selling any equity in the current holding company, BHC, whose fair value is meaningfully higher than its current share price, in our opinion. This fresh capital would allow for the creation of an investment grade BGE at inception while beginning to improve the credit ratios of the remainder of Bausch Health Companies. We believe this capital could come from a SPAC merger partner, private equity firm, leading North American or global investment institutions or the IPO market.
Icahn just bought a large stake in Bausch Health and sounds like they want to spin off the eye health division via a possible SPAC merger. Icahn owns half of $ENZN!
) PROCEED WITH PACE: The spin-off should be completed by year-end 2021.
In order to facilitate the spin-off of Bausch Global Eyecare as an investment grade Company, we recommend Bausch Health Companies retain a globally recognized investment banking firm to seek capital for an up to a 40% equity stake in BGE prior to its spin-off. To be clear, we are recommending raising capital by selling a stake in the eyecare subsidiary, BGE, at fair value, and we specifically recommend against selling any equity in the current holding company, BHC, whose fair value is meaningfully higher than its current share price, in our opinion. This fresh capital would allow for the creation of an investment grade BGE at inception while beginning to improve the credit ratios of the remainder of Bausch Health Companies. We believe this capital could come from a SPAC merger partner, private equity firm, leading North American or global investment institutions or the IPO market.
I really like that part of the article where it mentions a merger via a SPAC! Hello Enzon is right!!
Very interesting! Would be a wise move for ENZN to purchase a spun off eye care division, especially if that part of the business is profitable! It would be tax free income for them till the NOL’s are used up
There is no doubt that Icahn has exciting plans for $ENZN. I think something happens this year. So much potential
I’m hoping we have a 1 million+ volume day today to weed out the sellers. I won’t be Leary myself till I see insiders or the 10% holders selling.
Well one thing that is changing is the potential approval of Vicineum. The milestone payments and royalties will add a lot of cash. Enzon will get 0.75% of all sales of Vicineum. The potential worldwide annual sales could be as high as $3 billion once approved in US, Europe, China, etc. Assuming approval, ENZN would get $3.5 million milestone payments for each country it’s approved in along with a potential of up to $20+ million in royalty payments. This could be huge for ENZN.
We will find out on Monday the estimated date of FDA approval along with if it qualifies for fast track.
Yes, I know they do have the preferreds. However, that gives Enzon a total of about $48 million in cash now that they can use to acquire a company to use ENZN as a “Public company acquisition vehicle”
Also another positive is the comments from both the outgoing and incoming CEO’s that they made toward the bottom of the last PR.
If/when Vicineum is approved, I think ENZN could be a multi dollar stock. You should check out Vicineum when you have time. It’s looking like it has potential to treat other conditions besides bladder cancer. If that’s the case, we could be sitting on a gold mine here IMO
$MYRX it has to be close to our turn for a massive move higher lol
Oh wow, that is interesting. I wonder at what price most of those trades took place at during the last 5 minutes? I’m curious as to how tomorrow will turn out.
I noticed that the bid is .65 on OTC Markets right now. I’m thinking it might be a large volume day tomorrow. We’ll see
Your probably right. I just know that this will me much higher as the year goes on. We really shouldn’t be below .64 since ENZN has .64 in cash per share right now and zero debt.
Lesson learned for someone. Bad idea to do a market order on thin stocks like ENZN.
Hoping tomorrow we close back to near .80
All that in the last 5 minutes of trading too. Definitely looks like someone accidentally or purposely put in a market order for that sell
I totally agree with you. I think we need more days at these levels before moving higher. We all know it’s just a matter of time. Feb 16th is a big day for Vicineum. We will find out if it gets approved for fast track. We also find out what day the FDA will decide on possible approval.
This doesn’t even include ENZN buying a company for future growth like their website says.
It’s going to be a great year for sure!
Looks super thin now too!
Looks super thin now too!
Nice buy price! All I can say is that if/when Vicineum gets approved, $ENZN won’t see sub $1 anymore. And that’s doesn’t even include ENZN buying a profitable company to be public. That could be $5-$10 depending on the purchased company IMO